Skip to main content
. 2021 Nov 2;11:21439. doi: 10.1038/s41598-021-00863-w

Figure 1.

Figure 1

(A,B) Mean plasma levels of nucleosome and ICAM-1 in HVs, HD patients with the composite outcome, and HD patients without the composite outcome, and the between-group differences. (C) Mean ICAM-1 level according to nucleosome level Q1-3 and Q4 in HD patients (independent sample t-test). Patients with a higher nucleosome level had a significantly higher ICAM-1 level.